Kymera Investor Presentation Deck

● 7 # of Patients by AD-IGA Score P 10 LO N 0 Investigator's Global Assessment (VIGA-AD) 2 1 4 4 ||| 2 Day 14 1 Baseline VIGA-AD Score Over Time (n=7) KYMERA ©2023 KYMERA THERAPEUTICS, INC. ■ Mild 1 2 Day 28 Moderate ■Severe IGA scores remained stable or improved in all patients 1 2 Day 35 1 3 3 Day 42 PAGE 22

View entire presentation